Mirum Pharmaceuticals, Inc. today announced estimated revenue, including net product sales, and cash balance for the first quarter 2023.
The company’s preliminary unaudited financial results. | April 12, 2023
Marketing Authorization variation submitted for treatment of patients with progressive familial intrahepatic cholestasis two months of age and older; data supports treatment across the broadest. | April 5, 2023
Marketing Authorization variation submitted for treatment of patients with progressive familial intrahepatic cholestasis (PFIC) two months of age and older; data supports treatment across the broadest
Mirum Announces Label Expansion for LIVMARLI in the United States to Include Infants Three Months of Age and Older streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.